Cargando…

FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	French, Jacqueline A., Perucca, Emilio, Sander, Josemir W., Bergfeldt, Lennart, Baulac, Michel, Auerbach, David S., Keezer, Mark, Thijs, Roland D., Devinsky, Orrin, Vossler, David G., Welty, Timothy E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918301/ https://www.ncbi.nlm.nih.gov/pubmed/33681647 http://dx.doi.org/10.1002/epi4.12475

Ejemplares similares

FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force
por: French, Jacqueline A., et al.
Publicado: (2021)

Commentary: Message from the ILAE president
por: Perucca, Emilio
Publicado: (2016)

The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission
por: Najm, Imad, et al.
Publicado: (2022)

Paxlovid(TM) Information From FDA and Guidance for AES Members
por: Cokley, Jon A., et al.
Publicado: (2022)

The ILAE at 110—Reflections on the last decade
por: Wiebe, Samuel, et al.
Publicado: (2019)

Epilepsy priorities in Europe: A report of the ILAE‐IBE Epilepsy Advocacy Europe Task Force
por: Baulac, Michel, et al.
Publicado: (2015)

Preclinical common data elements (CDEs) for epilepsy: A joint ILAE/AES and NINDS translational initiative
por: Scharfman, Helen E., et al.
Publicado: (2018)

Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel‐modulating antiseizure medications
por: Nightscales, Russell, et al.
Publicado: (2023)

Turangal{circ}ila-symphonie
por: Messiaen, Olivier, 1908-
Publicado: (1991)

Institutional response to FDA warning on aprotinin and impact on outcomes
por: Swaminathan, M, et al.
Publicado: (2009)

Voting behavior during FDA Medical Device Advisory Committee panel meetings
por: Maisel-Campbell, Amanda, et al.
Publicado: (2022)

ILA Guidelines for Sustainable Natural Resources Management for Development
por: Cordonier Segger, Marie-Claire, et al.
Publicado: (2021)

A companion to the preclinical common data elements on neurobehavioral comorbidities of epilepsy: a report of the TASK3 behavior working group of the ILAE/AES Joint Translational Task Force
por: Mazarati, Andrey, et al.
Publicado: (2018)

Common data elements (CDEs) for preclinical epilepsy research: Introduction to CDEs and description of core CDEs. A TASK3 report of the ILAE/AES joint translational task force
por: Harte‐Hargrove, Lauren C., et al.
Publicado: (2018)

Classification of the epilepsies: New concepts for discussion and debate—Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology
por: Scheffer, Ingrid E., et al.
Publicado: (2016)

An ensemble of AHP-EW and AE-RNN for food safety risk early warning
por: Zhong, Jie, et al.
Publicado: (2023)

The Effects of the FDA Warning on the Use of Droperidol by U.S. Emergency Physicians
por: Richards, John R., et al.
Publicado: (2003)

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing
por: Yim, Seon-Hee, et al.
Publicado: (2014)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
por: Ichikado, Kazuya, et al.
Publicado: (2023)

Special Issue on the TASK3 Preclinical epilepsy Common Data Elements (CDEs) of the ILAE/AES Joint Translational Task Force: Peer review process, acknowledgement to reviewers, and community feedback
por: Galanopoulou, Aristea S., et al.
Publicado: (2018)

How do we use in vitro models to understand epileptiform and ictal activity? A report of the TASK1‐WG4 group of the ILAE/AES Joint Translational Task Force
por: Dulla, Chris G., et al.
Publicado: (2018)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
por: Hino, Takuya, et al.
Publicado: (2021)

Clinical features of hereditary angioedema and warning signs (H4AE) for its identification
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2022)

Highlights of an Expert Advisory Board on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) in Latin America
por: Naranjo, Laura, et al.
Publicado: (2020)

A companion to the preclinical common data elements for physiologic data in rodent epilepsy models. A report of the TASK3 Physiology Working Group of the ILAE/AES Joint Translational Task Force
por: Gorter, Jan A., et al.
Publicado: (2018)

Methodologic recommendations and possible interpretations of video‐EEG recordings in immature rodents used as experimental controls: A TASK1‐WG2 report of the ILAE/AES Joint Translational Task Force
por: Akman, Ozlem, et al.
Publicado: (2018)

Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
por: Werz, Mary Ann
Publicado: (2008)

Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis
por: Wang, QuanQiu, et al.
Publicado: (2018)

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
por: Chaloupka, Frank J, et al.
Publicado: (2015)

Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
por: Hagan, John B., et al.
Publicado: (2021)

Public Perceptions of Breast Implant Complications and the FDA Boxed Warning on Implants
por: Hyland, Colby J., et al.
Publicado: (2022)

A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
por: Barker‐Haliski, Melissa, et al.
Publicado: (2018)

A companion to the preclinical common data elements and case report forms for rodent EEG studies. A report of the TASK3 EEG Working Group of the ILAE/AES Joint Translational Task Force
por: Ono, Tomonori, et al.
Publicado: (2018)

Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks
por: Xiao, Fenglai, et al.
Publicado: (2018)

Advisory warning labels: what do dietitians advise parents of food-allergic children?
por: Turner, P, et al.
Publicado: (2013)

AES-Comments on AES offer
por: Gerard, M
Publicado: (1986)

Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs
por: Ahuja, Vishal, et al.
Publicado: (2015)

1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016
por: Willis, Zachary, et al.
Publicado: (2018)

Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning
por: Cook, Benjamin L., et al.
Publicado: (2019)

Unicorn Poo and Blessed Waters: COVID-19 Quackery and FDA Warning Letters
por: Bramstedt, Katrina A.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kjb6bc6fph9si0ml7ugt7kko42